A federal judge in Texas on Friday tossed a lawsuit brought by Humana that challenged the U.S. government's reduction in the ...

Humana Inc. lost its lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped ...

A Texas federal judge dismissed a lawsuit brought by health insurer Humana challenging the U.S. government's reduction in its ...

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare ...

Shares of health insurance company Humana (NYSE:HUM) fell 3.2% in the morning session after the company lost a lawsuit ...

The FDA panel voted against Otsuka's PTSD drug combination with Zoloft, questioning its efficacy. Getinge surpassed profit ...

Shares of Humana Inc. (NYSE: HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments ...

The company's stock has fallen sharply since it announced the Medicare ratings downgrade. On Oct. 1, the stock opened at $315. After the ruling Friday, the company's stock was down 2% to $219.04.

The FDA panel rejects Otsuka's PTSD drug combination. Humana's lawsuit challenging Medicare rating downgrades is dismissed. Spain reports an avian flu outbreak, causing global supply concerns.

Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted ...

A Texas federal judge dismissed a lawsuit brought by health insurer Humana challenging the U.S. Department of Health and ...

The company's stock has fallen sharply since it announced the Medicare ratings downgrade. On Oct. 1, the stock opened at $315. After the ruling Friday, the company's stock was down 2% to $219.04.